BIO · Bio-Rad Laboratories, Inc.

$327.02 -3.98 (-1.20%) At close · Jul 29

Market Cap

$8.86B

26.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$1,089,877	—	$4,856,574	$1,458,975	$562,088	$28,327	$7,995,841
Jonathan DiVincenzo	COO	$673,208	—	$2,023,696	$484,122	$476,702	$23,044	$3,680,772
Roop Lakkaraju	CFO	$629,100	—	$1,618,956	$387,358	$334,212	$21,112	$2,990,738
Rajat Mehta	Executive Vice President, Global Commercial Operations	$220,096	—	$2,158,707	—	$270,106	$31,133	$2,680,042
James Barry	Chief Financial Officer	$536,752	—	$1,214,217	$290,493	$266,079	$303,685	$2,611,227

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$1,059,500	—	$4,557,805	$2,280,086	$364,003	$28,077	$8,289,471
Jonathan DiVincenzo	COO	$204,515	$1,300,000	$2,453,382	—	$56,928	$299,260	$4,314,185
Roop Lakkaraju	CFO	$426,923	—	$3,225,018	—	$88,197	$34,937	$3,775,075

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$1,040,000	—	$6,211,537	—	—	$212,341	$7,463,878
Andrew Last	COO	$660,250	—	$2,587,795	—	—	$22,044	$3,270,089
Ilan Daskal	CFO	$565,093	—	$2,070,766	—	—	$20,112	$2,655,971
Dara Grantham Wright	Executive Vice President and President, Clinical Diagnostics Group	$562,390	—	$1,552,976	—	—	$17,760	$2,133,126
Simon May	President of Life Science Group	$517,813	—	$1,552,976	—	—	$18,432	$2,089,221

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$1,030,154	—	$5,398,348	—	$1,073,406	$26,077	$7,527,985
Andrew Last	COO	$638,566	—	$2,249,393	—	$457,382	$20,794	$3,366,135
Ilan Daskal	CFO	$580,241	—	$1,800,098	—	$353,331	$18,862	$2,752,532
Dara Grantham Wright	Executive Vice President and President, Clinical Diagnostics Group	$539,915	—	$1,349,830	—	$293,483	$16,130	$2,199,358
Simon May	President of Life Science Group	$499,737	—	$1,349,830	—	$270,845	$17,182	$2,137,594

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$987,885	—	$4,126,907	$1,423,476	$2,132,330	$25,327	$8,695,925
Andrew Last	COO	$610,760	—	$2,063,453	$603,703	$913,453	$20,044	$4,211,413
Ilan Daskal	CFO	$526,706	—	$1,485,654	$434,657	$639,314	$18,112	$3,104,443
Dara Grantham Wright	Executive Vice President and President, Clinical Diagnostics Group	$516,101	—	$1,321,034	$386,494	$531,576	$15,380	$2,770,585
Michael Crowley	Executive Vice President, Global Commercial Operations	$470,456	—	$1,321,034	$386,494	$483,186	$21,296	$2,682,466

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$986,538	—	$3,785,446	$1,193,773	$2,000,094	$26,572	$7,992,423
Andrew Last	COO	$612,346	—	$1,892,723	$532,987	$871,437	$14,659	$3,924,152
Ilan Daskal	CFO	$530,654	—	$1,135,634	$319,792	$612,844	$11,506	$2,610,430
Dara Grantham Wright	Executive Vice President and President, Clinical Diagnostics Group	$519,231	$200,000	$908,612	$255,863	$503,456	$164,498	$2,551,660
Annette Tumolo	President of Life Science Group	$518,635	—	$908,612	$255,863	$508,491	$24,918	$2,216,519
Michael Crowley	Executive Vice President, Global Commercial Operations	$473,580	—	$908,612	$255,863	$463,180	$14,664	$2,115,899

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$950,000	—	$3,865,744	$1,277,192	$1,143,383	$24,734	$7,261,053
Andrew Last	COO	$387,019	$50,000	$1,496,200	$412,894	$335,023	$53,625	$2,734,761
Ilan Daskal	CFO	$365,385	—	$1,084,440	$299,263	$256,259	$1,412	$2,006,759
Annette Tumolo	President of Life Science Group	$480,304	—	$928,019	$235,208	$270,062	$19,544	$1,933,137
Michael Crowley	Executive Vice President, Global Commercial Operations	$441,663	—	$928,019	$235,208	$203,229	$18,174	$1,826,293
Christine A. Tsingos	CFO	$200,688	—	—	—	$89,836	$14,730	$305,234

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$942,468	—	$4,239,950	$1,711,111	$490,200	$255,685	$7,639,414
Annette Tumolo	President of Life Science Group	$462,811	—	$978,450	$267,746	$133,386	$19,294	$1,861,687
Christine A. Tsingos	CFO	$438,150	—	$978,450	$267,746	$124,347	$19,234	$1,827,927
Michael Crowley	Executive Vice President, Global Commercial Operations	$427,724	—	$978,450	$267,746	$122,658	$17,924	$1,814,502

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Norman Schwartz	CEO	$922,022	—	$2,807,740	$1,012,928	$637,818	$24,168	$5,404,676
Christine A. Tsingos	CFO	$438,150	—	$647,940	$151,691	$151,547	$17,674	$1,407,002
Michael Crowley	Executive Vice President, Global Commercial Operations	$415,575	—	$647,940	$151,691	$158,113	$19,242	$1,392,561

Executive changes

Person	Role	Change	Effective	Filed
Gregory K. Hinckley	director	Appointed	2026-04-21	2026-04-24
Norman Schwartz	director	Appointed	2026-04-21	2026-04-24
Allison Schwartz	director	Appointed	2026-04-21	2026-04-24
Arnold A. Pinkston	director	Appointed	2026-04-21	2026-04-24
Jeffrey L. Edwards	director	Appointed	2026-04-21	2026-04-24
Melinda Litherland	director	Appointed	2026-04-21	2026-04-24

Key facts CIK 12208 CUSIP 090572207 13F (30d) 121 filings 94 filers Visit website Investor relations